生物医药的颠覆性，有时不在于“发现一个更强大的分子”。这家伦敦Biotech所做的，是将一种已有数千年历史的天然物质，转化为符合监管标准的现代药物，由此坐上“迷幻药先驱”的宝座。 撰文｜张烨静 首个“迷幻药”Ⅲ期临床，市值飙升400%，FDA政策护航 ...

Is CMPS a good stock to buy? We came across a bullish thesis on COMPASS Pathways plc on BioEquity Watch’s Substack. In this ...

根据公告，此次授予的股权奖励包括可购买总计15.7万股美国存托股的期权，以及针对英国员工的限制性股份单位或名义成本期权，共覆盖约7.47万股。期权行权价格为每股14.19美元，即授予日公司美国存托股在纳斯达克全球精选市场的收盘价。

Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways ...

LONDON, April 29, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today ...

LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of ...

Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Small ...

Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways ...

LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning ...